Scientech Research LLC Has $890,000 Stock Holdings in Cognex Corporation $CGNX

Scientech Research LLC grew its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 93.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 29,828 shares of the scientific and technical instruments company's stock after purchasing an additional 14,434 shares during the quarter. Scientech Research LLC's holdings in Cognex were worth $890,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Farther Finance Advisors LLC increased its position in shares of Cognex by 439.4% during the 1st quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock valued at $29,000 after purchasing an additional 791 shares during the period. GAMMA Investing LLC increased its position in shares of Cognex by 155.3% during the 1st quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock valued at $32,000 after purchasing an additional 646 shares during the period. UMB Bank n.a. increased its position in shares of Cognex by 105.5% during the 1st quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock valued at $38,000 after purchasing an additional 657 shares during the period. Global X Japan Co. Ltd. acquired a new position in shares of Cognex during the 1st quarter valued at $38,000. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Cognex by 82.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,749 shares of the scientific and technical instruments company's stock valued at $52,000 after purchasing an additional 791 shares during the period. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cognex

In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of the business's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the completion of the sale, the executive vice president owned 6,582 shares of the company's stock, valued at $296,387.46. The trade was a 23.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CGNX shares. DA Davidson lifted their target price on Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Citigroup restated a "neutral" rating and issued a $37.00 target price (up from $30.00) on shares of Cognex in a report on Monday, July 14th. Needham & Company LLC lifted their price target on Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a report on Thursday, July 31st. KeyCorp upgraded Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target on the stock in a report on Friday, August 1st. Finally, UBS Group lifted their price target on Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a report on Friday, August 1st. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Cognex has a consensus rating of "Moderate Buy" and a consensus target price of $42.31.

Cognex Stock Down 1.2%

Shares of NASDAQ:CGNX traded down $0.56 on Friday, reaching $44.39. The company had a trading volume of 1,405,568 shares, compared to its average volume of 1,809,277. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $45.23. The stock has a 50-day moving average price of $39.81 and a 200 day moving average price of $33.04. The stock has a market capitalization of $7.45 billion, a P/E ratio of 62.52 and a beta of 1.50.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The company had revenue of $249.09 million during the quarter, compared to analysts' expectations of $246.70 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business's quarterly revenue was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, sell-side analysts predict that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were given a $0.08 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. Cognex's payout ratio is currently 45.07%.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.